Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support directly.
Configurations
Workarounds
Exploits
Credits
finder
Joe Dillon reported these vulnerabilities to Mirion Medical.